Daniel Byun

Discovery of the First <i>C</i>-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients

Aesop Cho, Lijun Zhang, Jie Xu et al. · Journal of Medicinal Chemistry · 2013 · 125 citations

Viral Polymerase Structure, Adenosine Analogs, Hepatitis C Virus +17

Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV

Richard L. Mackman, Hon C. Hui, Michel Perron et al. · Journal of Medicinal Chemistry · 2021 · 79 citations · Full text

The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers

Rhonda J. Staversky, Daniel Byun, Mary Georger et al. · Scientific Reports · 2018 · 49 citations · Full text

Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase

Martijn Fenaux, Stacey Eng, Stephanie A. Leavitt et al. · Antimicrobial Agents and Chemotherapy · 2012 · 40 citations · Full text

Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection

Scott E. Lazerwith, Willard Lew, Jennifer Zhang et al. · Journal of Medicinal Chemistry · 2013 · 36 citations

Drug Target, Antiviral Drug, Chemical Biology +17